Market Cap (In USD)
5.06 Million
Revenue (In USD)
530 Thousand
Net Income (In USD)
-55.36 Million
Avg. Volume
19.96 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.87-10.8
- PE
- -
- EPS
- -
- Beta Value
- 1.318
- ISIN
- US68619K2042
- CUSIP
- 68619K204
- CIK
- 1460602
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ms. Vered Caplan M.Sc.
- Employee Count
- -
- Website
- https://www.orgenesis.com
- Ipo Date
- 2012-03-13
- Details
- Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.
More Stocks
-
0722
-
SMBKSmartFinancial, Inc.
SMBK
-
603615
-
0J51
-
0KEIPPG Industries, Inc.
0KEI
-
XIACYXiaomi Corporation
XIACY
-
CANNTrees Corporation
CANN
-
MTHRFM3, Inc.
MTHRF